60s RDN
Details
Date and registration
Ajay Kirtane
Ajay J. Kirtane, MD, SM, is a Professor of Medicine at Columbia University Medical Center and...
Read MoreAjay J. Kirtane, MD, SM, is a Professor of Medicine at Columbia University Medical Center and Director of the Cardiac Catheterization Laboratories at New York Presbyterian Hospital. Dr. Kirtane is a graduate of Princeton University and Columbia University College of Physicians and Surgeons, and completed his residency in Internal Medicine at the University of California – San Francisco. Dr. Kirtane is a practicing Cardiologist with an interest in coronary and peripheral intervention and assumed the directorship of the NYP/Columbia cardiac catheterization laboratories in 2015. In addition to his clinical commitments at CUMC, Dr. Kirtane has a strong interest in clinical education and research, serving as Chief Academic Officer of the Center for Interventional Vascular Therapy. On the national and international level, he is a co-director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics meeting, has served as a director of several international, national, and regional educational meetings, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association. Dr. Kirtane’s research interests are in clinical trial methodology and outcomes of device-based and pharmacologic interventions in Interventional Cardiology. He has authored/co-authored >150 original manuscripts and >50 reviews and chapters including the “Coronary Stenting” chapters of the two most widely used textbooks in Interventional Cardiology.
Show LessAloke Finn
Works at CVPath Institute, Inc., Gaithersburg, MD, USA. Features in 2 videos on Wondr Medical....
Read MoreWorks at CVPath Institute, Inc., Gaithersburg, MD, USA. Features in 2 videos on Wondr Medical. Aloke Finn generally speaks on Drug coated balloons (DCB), Primary Percutaneous Coronary Intervention (PPCI), Stents, Drug Eluting Stents (DES), and In-stent Restenosis (ISR).
Show LessDavid Kandzari
Dr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service...
Read MoreDr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service Line; Director, Interventional Cardiology of the Piedmont Heart Institute; and Chief Scientific Officer for Piedmont Healthcare in Atlanta, Georgia. Dr. Kandzari specializes in cardiovascular disease, peripheral arterial disease and interventional cardiology. A graduate of Duke University School of Medicine, he completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences. Dr. Kandzari is the former Director of Interventional Cardiology Research at the Scripps Clinic in La Jolla, California. Before joining the Scripps faculty, he also served as Chief Medical Officer for the Cordis Corporation, a Johnson & Johnson Company. He has also served as a Medical Officer for the Center for Devices and Radiological Health for the United States Food and Drug Administration. Board certified by the American Board of Internal Medicine and its subspecialty Board of Cardiovascular Disease and Board of Interventional Cardiology, Dr. Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 400 studies, book chapters and scientific reviews, and has delivered more than 700 lectures, both nationally and internationally, on a variety of issues related to both interventional and general cardiology. Dr. Kandzari has been consecutively voted as one of Atlanta's Top Doctors by Atlanta Magazine from 2011 to 2021, and is peer-nominated in the top 1% of cardiologists by U.S News and World Report.
Show LessHorst Sievert
A consultant cardiologist at CardioVascular Center, Frankfurt, Germany. Features in 63 videos on...
Read MoreA consultant cardiologist at CardioVascular Center, Frankfurt, Germany. Features in 63 videos on Wondr Medical. Horst Sievert generally speaks on Atrial Fibrillation, Left Atrial Appendage (Closure), Live Cases, Transcatheter Aortic Valve Implantation (TAVR / TAVI), and Left Main Stem (LMS).
Show LessJustin Davies
Dr Justin Davies is a honorary interventional cardiologist at Hammersmith Hospital, Imperial...
Read MoreDr Justin Davies is a honorary interventional cardiologist at Hammersmith Hospital, Imperial College NHS Trust, London. After training at Imperial College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to work on the development of mathematical algorithms to aid understanding of large artery physiology and to develop new tools to assess arterial disease. The holder of several patents, he has published widely in the field of hypertension, coronary and large artery physiology and is the winner of many national and international awards. He has several international collaborations, and is the developer of iFR and the co-principal investigator of the ADVISE studies, the DEFINE-FLAIR, ORBITA and DEFINE-PCI studies. Justin also has an interest in renal denervation, and has lead the first-in-man studies to evaluate the safety of this technique to patients with chronic systolic heart failure (REACH studies).
Show LessRobert Schwartz
Robert Schwartz works at Minneapolis Heart Institute Foundation, Inver Grove Heights, MN, USA.
Read MoreRobert Schwartz works at Minneapolis Heart Institute Foundation, Inver Grove Heights, MN, USA.
Show Less